Navigation Links
Guardant Health Announces Milestone Partnership with Robert H. Lurie Comprehensive Cancer Center of Northwestern University

REDWOOD CITY, Calif. and CHICAGO, Nov. 16, 2016 /PRNewswire/ -- Guardant Health Inc. announced today a comprehensive partnership with Northwestern University that will make Guardant360 the preferred liquid biopsy test for patients with advanced cancer treated at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. The agreement also covers multiple large-scale prospective clinical trials that will apply Guardant Health's technology to a variety of indications across the cancer-care continuum.

"As the Lurie Cancer Center OncoSET (Sequence, Evaluate, Treat) Program develops into an international leader in precision medicine, establishing a partnership for a liquid biopsy test was important," said Leonidas Platanias, MD, PhD, director of the Lurie Cancer Center. "Our program will benefit from Guardant Health's non-invasive technology. At the same time, we will promote and advance our precision oncology research by conducting large-scale prospective studies."

Together, Guardant Health and the Lurie Cancer Center will track the outcomes of patients with advanced cancer whose treatment selection was guided by Guardant360. In addition, every patient evaluated within the Lurie Cancer Center OncoSET Program will be enrolled in one of several prospective clinical trials exploring additional clinical uses of liquid biopsy.

Guardant360, the first comprehensive liquid biopsy, was introduced in 2014. It has been used by more than 2,500 oncologists to identify somatic genomic alterations associated with targeted therapies in the tumor DNA of more than 20,000 patients with advanced cancer. 

"The future of cancer diagnostics lies in minimally-invasive sampling methods and sophisticated, sensitive testing. With Guardant Health's liquid biopsy, we can access our patients' comprehensive genomic information with minimal risk," said Massimo Cristofanilli, MD, Associate Director for Translational Research and Precision Medicine at the Lurie Cancer Center, and Director of the OncoSET Program. "This collaboration will help us determine the value of prospective molecular monitoring in patients with advanced disease by exploring the potential of liquid biopsy specifically, and precision oncology in general, to impact lives."

"We are excited to partner with Northwestern, one of the world's leading cancer centers," said Helmy Eltoukhy, PhD, Guardant Health's co-founder and CEO. "Lurie Cancer Center clinicians have already used our technology to guide treatment for hundreds of patients, and this agreement speaks to the utility of our technology. It demonstrates a real desire among oncologists and their patients for a 'blood-first' liquid biopsy approach to advanced cancer genotyping."

About Lurie Cancer Center

The Robert H. Lurie Comprehensive Cancer Center of Northwestern University, one of only 47 National Cancer Institute-designated Comprehensive Cancer Centers in the country, is committed to being a national leader in the battle to overcome cancer. To this end, the Lurie Cancer Center is dedicated to scientific discovery, advancing medical knowledge, providing compassionate, state-of-the-art cancer care, and training the next generation of clinicians and scientists.  For more information, visit

About Guardant Health

Guardant Health, headquartered in Redwood City, Calif., is focused on developing breakthrough diagnostics that can transform cancer into a manageable disease. Guardant Health was founded in 2012 by a team of entrepreneurs with expertise in next-generation sequencing, single-cell genomics, and cancer diagnostics. The company has raised more than $200 million from leading venture capital firms. Its first product, Guardant360, came to market in 2014, and is now the most validated and sensitive comprehensive liquid biopsy commercially available.


To view the original version on PR Newswire, visit:

SOURCE Guardant Health
Copyright©2016 PR Newswire.
All rights reserved

Related medicine technology :

1. Guardant Health to Present at the WedBush 2014 Life Sciences Management Access Conference
2. Guardant Health Presents Data on Biopsy-Free Tumor Genomic Profiling Of More Than 2000 Clinical Samples via Guardant360
3. Guardant Health Appoints Mort Minaee, Former Roche Senior Director, as VP of Regulatory Affairs
4. Van Dyk Invests In Key Resources To Prepare For Healthcare Reform
5. Cumberland Pharmaceuticals To Present At The UBS Global Healthcare Conference In New York
6. North America Home Healthcare Market Worth $130.4 Billion by 2017
7. Pentec Health Announces Limited Voluntary Recall of Certain Compounded Prescription Therapies for Renal Patients
8. Physician-Patient Alliance for Health & Safety Announces Four Essentials for Safety for Patients Receiving Opioids
9. The Zacks Analyst Blog Highlights: Genomic Health, Sanofi, Regeneron Pharmaceuticals, Amgen and Isis Pharmaceuticals
10. Wireless Pill Bottle Wins Healthcare Innovation World Cup
11. AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference
Post Your Comments:
(Date:9/17/2019)... ... September 17, 2019 , ... For the 6th year in a row, Mental ... ranks all 50 states and the District of Columbia based on several mental health and ... The report also takes a look back on the trends of the last 6 years ...
(Date:9/17/2019)... ... ... Drs. Nickelice Brand and Chris Williams restore smiles of Ocala, FL patients ... implants are a nearly permanent, comfortable and efficient way for patients to replace their ... when placed by highly trained professionals such as Drs. Brand and Williams, providing patients ...
(Date:9/17/2019)... ... , ... Embr Labs , the breakthrough thermal technology company and creator ... DigiTx Partners, with participation from Safar Partners, Joyance Partners , Bose ... company’s footprint in wellness and digital therapeutics, accelerate development for the next generation of ...
Breaking Medicine Technology:
(Date:9/17/2019)... , ... September 17, 2019 , ... ... is pleased to announce the release of the third edition of The Gift ... easy-to-read guide for patients, caregivers and families to navigate the clinical research process. ...
(Date:9/17/2019)... ... September 17, 2019 , ... ... Open House day on Pacifica's Lambert Campus, 249 Lambert Road, Carpinteria, CA. ... the Humanities, Clinical Psychology, Counseling Psychology, and Mythological Studies. Program Faculty will ...
(Date:9/14/2019)... ... ... GreenTheVoteOk , one of the most reliable online resource providers on ... relevant and important developments in the fast-changing world of legalized CBD. , With ... the world suffering from different difficult-to-treat ailments, people need to identify brands that offer ...
(Date:9/11/2019)... ... 2019 , ... “Heart Seizures”: a useful source of knowledge that tells about ... to prevent anyone from having it and to help those who are suffering with ... was diagnosed with coronary artery disease. Predicted to experience another probable heart attack six ...
(Date:9/11/2019)... ... , ... A September 2 article on CBS News details a ... likely to suffer heart attacks, strokes, kidney failure, and heart disease versus a control ... surgery specialists Dr. Feiz and Associates says the study adds further evidence to an ...
Breaking Medicine News(10 mins):